Stericycle Inc  

(Public, NASDAQ:SRCL)   Watch this stock  
Find more results for SRCL
109.35
-1.53 (-1.38%)
Real-time:   2:36PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 109.08 - 110.95
52 week 87.63 - 113.11
Open 110.90
Vol / Avg. 156,069.00/403,621.00
Mkt cap 9.43B
P/E 34.34
Div/yield     -
EPS 3.18
Shares 86.28M
Beta 0.23
Inst. own 90%
Jun 18, 2013
Stericycle at Northcoast Research Healthcare Forum
Jun 13, 2013
Stericycle at William Blair Growth Stock Conference
Jun 11, 2013
Stericycle at Goldman Sachs Healthcare Conference
Jun 5, 2013
Stericycle at Jefferies Global Healthcare Conference
May 21, 2013
Stericycle Annual Shareholder Meeting
May 16, 2013
Stericycle at Bank of America Merrill Lynch Health Care Conference
May 7, 2013
Stericycle at Robert W Baird and Co Growth Stock Conference
Apr 24, 2013
Q1 2013 Stericycle Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 14.64% 14.11%
Operating margin 25.61% 24.51%
EBITD margin - 30.01%
Return on average assets 8.51% 8.03%
Return on average equity 19.00% 19.56%
Employees 12,598 -
Carbon Disclosure Rating - -

Address

28161 N. Keith Drive
LAKE FOREST, IL 60045
United States - Map
+1-847-3675910 (Phone)
+1-847-3679493 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Stericycle, Inc., is in the business of managing regulated waste and providing an array of related and complementary services. The regulated waste services it provides include medical waste disposal, Steri-Safe medical waste and compliance program,Clinical Services program, Bio Systems reusable sharps disposal management services, pharmaceutical waste disposal, and hazardous waste disposal. In addition to the Company's regulated waste services, it offers regulated recall and returns management services, patient communication services, and medical safety products. The Company's regulated recall and returns management services consist of a number of solutions for a variety of businesses but consist primarily of managing the recall, withdrawal or return of expired or recalled products and pharmaceuticals. During the year ended December 31, 2012, it completed 41 acquisitions, of which 17 were domestic businesses and 24 were international businesses in Latin America, Europe, and Japan.

Officers and directors

Mark C. Miller Executive Chairman of the Board
Age: 57
Bio & Compensation  - Reuters
Charles A. Alutto President, Chief Executive Officer, Director
Age: 47
Bio & Compensation  - Reuters
Frank J. M. ten Brink Chief Financial Officer, Executive Vice President, Chief Administrative Officer
Age: 56
Bio & Compensation  - Reuters
Richard T. Kogler Chief Operating Officer, Executive Vice President
Age: 53
Bio & Compensation  - Reuters
Michael J. Collins Executive Vice President, President - Recall and Returns Management Services
Age: 56
Bio & Compensation  - Reuters
Jack W. Schuler Lead Independent Director
Age: 72
Bio & Compensation  - Reuters
Thomas D. Brown Independent Director
Age: 65
Bio & Compensation  - Reuters
Rodney F. Dammeyer Independent Director
Age: 72
Bio & Compensation  - Reuters
William K. Hall Independent Director
Age: 69
Bio & Compensation  - Reuters
Jonathan T. Lord M.D. Independent Director
Age: 58
Bio & Compensation  - Reuters